SMTL ID : 3bjc.1

Crystal structure of the PDE5A catalytic domain in complex with a novel inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.620, H.656, D.657, D.767 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.620, A:H.656, A:D.657, A:D.767, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: H.616, D.657, H.660 Ligands: ZN.1 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.657, H2O.1

1 x WAN: 5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide(Non-covalent)

WAN.3: 11 residues within 4Å: Chain A: H.616, L.768, A.770, I.771, A.782, V.785, A.786, F.789, M.819, Q.820, F.823 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.786, A:F.789, A:F.789, A:F.823 Hydrogen bonds: A:M.819, A:Q.820, A:Q.820 Water bridges: A:Y.615 pi-Stacking: A:F.823

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, G. et al., An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies. BIOCHEM.PHARM. (2008)

Release Date

2008-04-29

Peptides

cGMP-specific 3',5'-cyclic phosphodiesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cGMP-specific 3',5'-cyclic phosphodiesterase